Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
GenFleet Therapeutics (Shanghai) Inc. (2595)
Market Closed
12 Aug, 08:00
HKEX
All
(1)
HK
(1)
HKEX
Primary
30.
40
HKD
-0.24
-0.7833%
HKD
10.61B
Market Cap
-
P/E Ratio
-
Div Yield
1.39M
Volume
-
Eps
30.64
HKD
Previous Close
Watching
Watch
Add Transaction
Day Range
29.34
31.18
Year Range
19.6
52.9
Want to track
2595
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
GenFleet Therapeutics (Shanghai) Inc. (2595) Statistics
Valuation metrics
Market Cap
10.61B
Enterprise value
23.84B
Trailing P/E (ttm)
-5.55
Forward P/E
-49.29
PEG ratio
-49.29
Price/Sales (ttm)
97.01
Price/Book (mrq)
10.76
Enterprise Value/Revenue
158.09
Enterprise Value/EBITDA
-75.01
Overview
Shares outstanding
370.37M
Float
485.54M
Shares short
-
% Held by insiders
0.2%
% Held by institutions
0.22%
Average volume (10 days)
1.23M
Average volume (90 days)
1.42M
Price summary
52-Week low
19.6
52-Week high
52.9
Beta
-
50-Day moving average
37.44
200-Day moving average
32.22
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.64%
Operating margin
-4.63%
Operational effectiveness
Return on assets
-0.12%
Return on equity
-0.99%
Income Statement
Revenue (ttm)
150.8M
Revenue per share (ttm)
0.44
Quarterly revenue growth (yoy)
-0.6%
Gross profit (ttm)
96.84M
EBITDA
-317.8M
Net income to common (ttm)
-2.08B
Diluted EPS (ttm)
-7.02
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
2.4B
Total cash per share (mrq)
3.14
Total debt (mrq)
116.83M
Total Debt/Equity (mrq)
5.56
Current ratio (mrq)
5.85%
Book value per share (mrq)
3.17
Cash Flow
Cash flow statement
-157.09M
Levered free cash flow (LFCF)
-2.56B